NASDAQ · FORR

Forrester Research Inc.

$9.51 +$0.64 (+7.22%) 1D Market open
Charting by TradingView

Key Metrics

$172.18M
Market cap
—
P/E · TTM
$392.47M
Revenue · TTM
−$53.91M
Net income
EPS · TTM $-2.85
Dividend yield —
Free cash flow $11.40M
Beta · 1Y 0.42
EBITDA · TTM −$43.84M
Gross margin —

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Apr 10
    From its Feb 2 high, the share price fell 38%.

    Peak close $8.13 on Feb 2; trough close $5.05 on Apr 10. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -38%
  • Feb 23
    The stock moved -9.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 23
  • Feb 3
    The stock moved -12.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 3

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$172.18M
Enterprise value$133.28M
Shares outstanding19.4M
52-wk range$4.88 – $11.57
Avg volume · 20D75.9K
Net cash $38.90M
Book value / share$5.61
IndustryServices-Engineering, Accounting, Research, Management
ExchangeNASDAQ
About Forrester Research Inc.
IPO dateNov 27, 1996
Employees1474

Forrester Research Inc provides independent research, data, and advisory services.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E—
P/S0.44
P/FCF15.11
EV/EBITDA—
EV/Sales0.34
Graham №—

Profitability

Gross —
Operating -12.7%
Net -13.7%
FCF 2.9%
ROE / ROIC -32.1% · -80.3%

Financial Health

Current ratio0.92
Quick ratio—
Debt / equity0.33
Debt / EBITDA -0.80
Net cash $38.90M
Working capital−$19.51M

Cash Flow · TTM

Operating CF $19.94M
Capex −$8.54M
Free cash flow $11.40M
Buybacks —
Dividends paid —
Shareholder yield —

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

0.9
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

—
Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings